| P41145 |
BXGT010225 |
Kappa-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRK1 |
Inhibition |
'=' |
47 |
% |
| P42866 |
BXGT010343 |
Mu-type opioid receptor |
reviewed |
- |
Oprm1 |
Inhibition |
'=' |
97 |
% |
| P41145 |
BXGT010225 |
Kappa-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRK1 |
EC50 |
'=' |
16000 |
nM |
| P33533 |
BXGT009729 |
Delta-type opioid receptor |
reviewed |
- |
Oprd1 |
Ki |
'=' |
1087 |
nM |
| P33534 |
BXGT009730 |
Kappa-type opioid receptor |
reviewed |
- |
Oprk1 |
EC50 |
'=' |
16000 |
nM |
| Q14994 |
BXGT013519 |
Nuclear receptor subfamily 1 group I member 3 |
reviewed |
Nuclear receptor |
NR1I3 |
Activity |
- |
- |
- |
| P41144 |
BXGT010224 |
Kappa-type opioid receptor |
reviewed |
- |
OPRK1 |
Ki |
'>' |
10000 |
nM |
| O42275 |
BXGT004559 |
Acetylcholinesterase |
reviewed |
- |
ache |
Inhibition |
'=' |
80 |
% |
| O42275 |
BXGT004559 |
Acetylcholinesterase |
reviewed |
- |
ache |
IC50 |
'=' |
76200 |
nM |
| P35869 |
BXGT009877 |
Aryl hydrocarbon receptor |
reviewed |
Transcription factor |
AHR |
Activity |
- |
- |
- |
| P33535 |
BXGT009731 |
Mu-type opioid receptor |
reviewed |
- |
Oprm1 |
Selectivity ratio |
'=' |
25 |
- |
| P33533 |
BXGT009729 |
Delta-type opioid receptor |
reviewed |
- |
Oprd1 |
Selectivity ratio |
'=' |
25 |
- |
| P33535 |
BXGT009731 |
Mu-type opioid receptor |
reviewed |
- |
Oprm1 |
Ki |
'=' |
43 |
nM |
| P33533 |
BXGT009729 |
Delta-type opioid receptor |
reviewed |
- |
Oprd1 |
Ki |
'>' |
10000 |
nM |
| P41143 |
BXGT010223 |
Delta-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRD1 |
Inhibition |
'=' |
93 |
% |
| P41143 |
BXGT010223 |
Delta-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRD1 |
EC50 |
'=' |
4000 |
nM |
| P33535 |
BXGT009731 |
Mu-type opioid receptor |
reviewed |
- |
Oprm1 |
Ki |
'>' |
10000 |
nM |
| P54855 |
BXGT011088 |
UDP-glucuronosyltransferase 2B15 |
reviewed |
- |
UGT2B15 |
Activity |
'=' |
0 |
pm/min/mg |
| P22310 |
BXGT008754 |
UDP-glucuronosyltransferase 1-4 |
reviewed |
- |
UGT1A4 |
Activity |
'=' |
0 |
pm/min/mg |
| P35372 |
BXGT009823 |
Mu-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRM1 |
Inhibition |
'=' |
93 |
% |
| P35372 |
BXGT009823 |
Mu-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRM1 |
EC50 |
'=' |
500 |
nM |
| P35372 |
BXGT009823 |
Mu-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRM1 |
EC50 |
'=' |
478 |
nM |
| O35627 |
BXGT004535 |
Nuclear receptor subfamily 1 group I member 3 |
reviewed |
- |
Nr1i3 |
Activity |
- |
- |
- |
| P33534 |
BXGT009730 |
Kappa-type opioid receptor |
reviewed |
- |
Oprk1 |
Inhibition |
'=' |
59 |
% |
| O75469 |
BXGT005128 |
Nuclear receptor subfamily 1 group I member 2 |
reviewed |
Nuclear receptor |
NR1I2 |
Activity |
- |
- |
- |
| P34975 |
BXGT009780 |
Kappa-type opioid receptor |
reviewed |
- |
Oprk1 |
Ki |
'=' |
2658 |
nM |
| Q9R1A7 |
BXGT021413 |
Nuclear receptor subfamily 1 group I member 2 |
reviewed |
- |
Nr1i2 |
Activity |
- |
- |
- |
| P42866 |
BXGT010343 |
Mu-type opioid receptor |
reviewed |
- |
Oprm1 |
EC50 |
'=' |
160 |
nM |
| P35372 |
BXGT009823 |
Mu-type opioid receptor |
reviewed |
G-protein coupled receptor |
OPRM1 |
Ki |
'=' |
133 |
nM |